Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes

BACKGROUND: Sodium-glucose co-transporter 2 inhibitors have been shown to reduce body weight. However, little is known about whether a reduction in body weight affects glycemic and non-glycemic parameters. OBJECTIVES: The aim of this study was to investigate the link between the changes in body weig...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutoh, Eiji, Murayama, Teruma, Wada, Asuka, Hirate, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114207/
https://www.ncbi.nlm.nih.gov/pubmed/27798769
http://dx.doi.org/10.1007/s40268-016-0149-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114207/
https://www.ncbi.nlm.nih.gov/pubmed/27798769
http://dx.doi.org/10.1007/s40268-016-0149-5

Ejemplares similares